Iterum Therapeutics plc Insider Trading
ITRMF
No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Nov 2025.
Get an email when ITRMF's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | Michael W. Dunne Director | Bought | 6,000 | $0.37 | 2K | 2.6% | Form 4 |
| Aug 8, 2025 | Michael W. Dunne Director | Bought | 15,000 | $0.72 | 11K | 6.8% | Form 4 |
- Nov 18, 2025Michael W. DunneDirector · bought 6,000 at $0.372K2.6% of stake
- Aug 8, 2025Michael W. DunneDirector · bought 15,000 at $0.7211K6.8% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with ITRMF
Spot a number that looks wrong? Check it in ITRMF's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ITRMF
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.